Association of
ART
CYP2B6 gene
HIV
drug resistance selection
fast metabolizers
Journal
Pharmacogenomics and personalized medicine
ISSN: 1178-7066
Titre abrégé: Pharmgenomics Pers Med
Pays: New Zealand
ID NLM: 101514107
Informations de publication
Date de publication:
2021
2021
Historique:
received:
10
11
2020
accepted:
22
02
2021
entrez:
24
3
2021
pubmed:
25
3
2021
medline:
25
3
2021
Statut:
epublish
Résumé
CYP2B6 liver enzyme metabolizes the two non-nucleoside reverse transcriptase inhibitors Efavirenz (EFV) and Nevirapine (NVP) used in the antiretroviral therapy (ART) regimens for HIV-infected individuals. Polymorphisms of the Participants were a sub-sample of a larger study (Tshepo study) conducted in Gaborone, Botswana, among HIV-infected individuals taking EFV/NVP containing ART. Study samples were retrieved and assigned to cases (with DRMs) and controls (without DRMs). Four single-nucleotide polymorphisms (SNPs) in the Two hundred and twenty-seven samples were analysed (40 with DRMs, 187 without DRMs). BLR analysis showed an association between EFV/NVP resistance and We demonstrated that the
Identifiants
pubmed: 33758532
doi: 10.2147/PGPM.S289471
pii: 289471
pmc: PMC7981136
doi:
Types de publication
Journal Article
Langues
eng
Pagination
335-347Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : P30 AI045008
Pays : United States
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2021 Maseng et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
J Infect Dis. 2013 Feb 15;207(4):687-8
pubmed: 23204183
Pharmacogenomics J. 2012 Dec;12(6):499-506
pubmed: 21862974
Clin Infect Dis. 2006 Feb 1;42(3):401-7
pubmed: 16392089
Curr Opin HIV AIDS. 2019 Nov;14(6):442-448
pubmed: 31449090
Br J Clin Pharmacol. 2009 Apr;67(4):427-36
pubmed: 19371316
J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):400-4
pubmed: 22481606
J Antimicrob Chemother. 2010 Dec;65(12):2614-9
pubmed: 20952418
PLoS One. 2014 Jan 31;9(1):e86919
pubmed: 24497997
PLoS One. 2013 Jul 05;8(7):e67946
pubmed: 23861838
HIV Med. 2007 Mar;8(2):86-91
pubmed: 17352764
N Engl J Med. 2019 Jul 18;381(3):230-242
pubmed: 31314967
J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):488-491
pubmed: 28481785
AIDS Res Hum Retroviruses. 2016 Jun;32(6):529-38
pubmed: 26655325
Malar J. 2014 Nov 03;13:420
pubmed: 25363545
Br J Clin Pharmacol. 2015 Jul;80(1):146-56
pubmed: 25611810
Pharmacogenomics. 2015;16(12):1343-54
pubmed: 26244421
Pharmacogenet Genomics. 2012 Dec;22(12):868-76
pubmed: 23104099
J Pharmacol Exp Ther. 2006 Jul;318(1):345-51
pubmed: 16611850
Eur J Clin Pharmacol. 2006 Apr;62(4):267-75
pubmed: 16506047
Pharmacogenomics J. 2018 Sep;18(5):678-688
pubmed: 29855606
J Antimicrob Chemother. 2014 Feb;69(2):491-9
pubmed: 24080498
Pharmacogenet Genomics. 2005 Jan;15(1):1-5
pubmed: 15864119
J Antimicrob Chemother. 2018 Jan 1;73(1):165-172
pubmed: 29029267
AIDS. 2012 Oct 23;26(16):2097-106
pubmed: 22951632
Pharmacogenomics. 2007 Jun;8(6):547-58
pubmed: 17559344
Pharmacogenet Genomics. 2005 Dec;15(12):861-73
pubmed: 16272958
OMICS. 2015 Sep;19(9):553-62
pubmed: 26348712
J Infect Dis. 2011 Dec 1;204(11):1772-8
pubmed: 21998472
Pharmacogenet Genomics. 2015 Feb;25(2):51-9
pubmed: 25461247
Sci Rep. 2018 Nov 5;8(1):16316
pubmed: 30397233
Br J Clin Pharmacol. 2007 Sep;64(3):391-5
pubmed: 17391322
AIDS. 2004 Dec 3;18(18):2391-400
pubmed: 15622315
Mol Pharmacol. 2005 May;67(5):1772-82
pubmed: 15722458
Am J Ther. 2016 Nov/Dec;23(6):e1715-e1719
pubmed: 26938766
J Antimicrob Chemother. 2011 Oct;66(10):2350-61
pubmed: 21846671
Pharmacogenet Genomics. 2006 Mar;16(3):191-8
pubmed: 16495778
Appl Clin Genet. 2019 Dec 30;12:261-268
pubmed: 31920362
Malar J. 2017 Jul 3;16(1):267
pubmed: 28673292
AIDS. 2009 Oct 23;23(16):2101-6
pubmed: 19779319
Pharmacogenomics J. 2016 Feb;16(1):88-95
pubmed: 25963334
Infect Genet Evol. 2016 Jan;37:192-207
pubmed: 26602158
Pharmacogenet Genomics. 2013 Aug;23(8):415-27
pubmed: 23778320
EBioMedicine. 2015 May 12;2(7):706-12
pubmed: 26288843
Infect Genet Evol. 2015 Oct;35:122-6
pubmed: 26247717
Mol Ecol Resour. 2010 May;10(3):564-7
pubmed: 21565059
AIDS Res Ther. 2015 Apr 15;12:10
pubmed: 25878720
Antiviral Res. 2014 Feb;102:44-53
pubmed: 24316028
J Antimicrob Chemother. 2019 Jan 1;74(1):135-138
pubmed: 30239753
Hum Mutat. 2013 May;34(5):725-34
pubmed: 23418033
J Infect Dis. 2005 Dec 1;192(11):1931-42
pubmed: 16267764
Pharmacogenomics. 2007 Jul;8(7):743-59
pubmed: 17638512
Pharmacogenet Genomics. 2009 Apr;19(4):300-9
pubmed: 19238117
Eur J Clin Pharmacol. 2008 Apr;64(4):357-65
pubmed: 18057928
AIDS. 2011 Jun 19;25(10):1271-80
pubmed: 21505298
BMC Infect Dis. 2013 Jun 04;13:261
pubmed: 23734829
J Infect Dis. 2010 Sep 1;202(5):717-22
pubmed: 20662624
Drug Metab Dispos. 1999 Dec;27(12):1488-95
pubmed: 10570031
J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):336-7
pubmed: 18978480
AIDS. 2017 Sep 24;31(15):2107-2113
pubmed: 28692529
Br J Clin Pharmacol. 2012 Jul;74(1):134-40
pubmed: 22680342
Eur J Clin Pharmacol. 2013 Nov;69(11):1909-16
pubmed: 23774940
Pharmacogenomics. 2014 Feb;15(3):385-400
pubmed: 24533717
Antivir Ther. 2009;14(5):687-95
pubmed: 19704172
Clin Pharmacol Ther. 2008 Feb;83(2):234-42
pubmed: 17971818
J Antimicrob Chemother. 2019 Oct 1;74(10):3003-3010
pubmed: 31299074
Ther Drug Monit. 2010 Oct;32(5):573-8
pubmed: 20625352
OMICS. 2017 Aug;21(8):465-473
pubmed: 28816644
JAMA. 2011 Apr 6;305(13):1327-35
pubmed: 21467286
Br J Clin Pharmacol. 2009 Nov;68(5):690-9
pubmed: 19916993
Antimicrob Agents Chemother. 2014;58(2):706-12
pubmed: 24217698
Pharmacogenet Genomics. 2011 Nov;21(11):721-30
pubmed: 21860339
BMC Pharmacol Toxicol. 2015 Mar 27;16:4
pubmed: 25889207
Malays J Med Sci. 2013 Jul;20(4):13-23
pubmed: 24043992
Int J Infect Dis. 2019 May;82:111-116
pubmed: 30818046
Sci Rep. 2018 Mar 20;8(1):4912
pubmed: 29559695
Antimicrob Agents Chemother. 2017 Jul 25;61(8):
pubmed: 28559276
AIDS Res Ther. 2010 Aug 19;7:32
pubmed: 20723261
J Antimicrob Chemother. 2014 Aug;69(8):2187-90
pubmed: 24695352
AIDS. 2010 Jan;24 Suppl 1:S27-36
pubmed: 20023437
J Infect Dis. 2013 Jun 15;207 Suppl 2:S57-62
pubmed: 23687290
Clin Pharmacol Ther. 2019 Oct;106(4):726-733
pubmed: 31006110
Biol Pharm Bull. 2016;39(1):84-9
pubmed: 26725431
Eur J Clin Pharmacol. 2012 Mar;68(3):267-71
pubmed: 21901344